APA
Velaparthi U., Darne C. P., Warrier J., Liu P., Rahaman H., Augustine-Rauch K., Parrish K., Yang Z., Swanson J., Brown J., Dhar G., Anandam A., Holenarsipur V. K., Palanisamy K., Wautlet B. S., Fereshteh M. P., Lippy J., Tebben A. J., Sheriff S., Ruzanov M., Yan C., Gupta A., Gupta A. K., Vetrichelvan M., Mathur A., Gelman M., Singh R., Kinsella T., Murtaza A., Fargnoli J., Vite G. & Borzilleri R. M. (2020). Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent. : ACS medicinal chemistry letters.
Chicago
Velaparthi Upender, Darne Chetan Padmakar, Warrier Jayakumar, Liu Peiying, Rahaman Hasibur, Augustine-Rauch Karen, Parrish Karen, Yang Zheng, Swanson Jesse, Brown Jennifer, Dhar Gopal, Anandam Aravind, Holenarsipur Vinay K, Palanisamy Kamalavenkatesh, Wautlet Barri S, Fereshteh Mark P, Lippy Jonathan, Tebben Andrew J, Sheriff Steven, Ruzanov Max, Yan Chunhong, Gupta Anuradha, Gupta Arun Kumar, Vetrichelvan Muthalagu, Mathur Arvind, Gelman Marina, Singh Rajinder, Kinsella Todd, Murtaza Anwar, Fargnoli Joseph, Vite Gregory and Borzilleri Robert M. 2020. Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent. : ACS medicinal chemistry letters.
Harvard
Velaparthi U., Darne C. P., Warrier J., Liu P., Rahaman H., Augustine-Rauch K., Parrish K., Yang Z., Swanson J., Brown J., Dhar G., Anandam A., Holenarsipur V. K., Palanisamy K., Wautlet B. S., Fereshteh M. P., Lippy J., Tebben A. J., Sheriff S., Ruzanov M., Yan C., Gupta A., Gupta A. K., Vetrichelvan M., Mathur A., Gelman M., Singh R., Kinsella T., Murtaza A., Fargnoli J., Vite G. and Borzilleri R. M. (2020). Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent. : ACS medicinal chemistry letters.
MLA
Velaparthi Upender, Darne Chetan Padmakar, Warrier Jayakumar, Liu Peiying, Rahaman Hasibur, Augustine-Rauch Karen, Parrish Karen, Yang Zheng, Swanson Jesse, Brown Jennifer, Dhar Gopal, Anandam Aravind, Holenarsipur Vinay K, Palanisamy Kamalavenkatesh, Wautlet Barri S, Fereshteh Mark P, Lippy Jonathan, Tebben Andrew J, Sheriff Steven, Ruzanov Max, Yan Chunhong, Gupta Anuradha, Gupta Arun Kumar, Vetrichelvan Muthalagu, Mathur Arvind, Gelman Marina, Singh Rajinder, Kinsella Todd, Murtaza Anwar, Fargnoli Joseph, Vite Gregory and Borzilleri Robert M. Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent. : ACS medicinal chemistry letters. 2020.